Page last updated: 2024-08-21

pyrazines and amiodarone

pyrazines has been researched along with amiodarone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blackburn, KJ; Burges, RA; Cross, PE; Dalrymple, HW; Dickinson, RP; Gwilt, M; Higgins, AJ1
Cheng, J; Kamiya, K; Kodama, I; Lee, JK; Suzuki, R; Toyama, J1
Boucher, BJ1
Becker, S; Brodt, HR; de Leuw, P; Grünewald, T; Kann, G; Kempf, VA; Keppler, OT; Stephan, C; Vogl, T; Wolf, T; Zacharowski, K1

Reviews

1 review(s) available for pyrazines and amiodarone

ArticleYear
Ion channel blockers in the treatment of chronic heart failure.
    Journal of cardiac failure, 1996, Volume: 2, Issue:4 Suppl

    Topics: Amiodarone; Animals; Calcium Channel Blockers; Chronic Disease; Heart Failure; Humans; Potassium Channel Blockers; Pyrazines; Quinolines

1996

Other Studies

3 other study(ies) available for pyrazines and amiodarone

ArticleYear
Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:3

    Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dogs; Dose-Response Relationship, Drug; Heart; Heart Conduction System; In Vitro Techniques; Male; Purkinje Fibers; Pyrazines; Pyridines; Refractory Period, Electrophysiological

1991
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. But what about the amiodarone?
    Diabetic medicine : a journal of the British Diabetic Association, 2009, Volume: 26, Issue:2

    Topics: Amiodarone; Contraindications; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pyrazines; Renal Insufficiency; Rhabdomyolysis; Simvastatin; Sitagliptin Phosphate; Triazoles; United Kingdom; United States

2009
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care.
    Lancet (London, England), 2015, Apr-11, Volume: 385, Issue:9976

    Topics: Adult; Amides; Amiodarone; Anti-Infective Agents; Antiviral Agents; Blood Vessels; Critical Care; Fibrin Fibrinogen Degradation Products; Hemorrhagic Fever, Ebola; Humans; Intubation, Intratracheal; Male; Multiple Organ Failure; Patient Isolation; Peptide Fragments; Pulmonary Edema; Pyrazines; Radiography, Thoracic; Renal Insufficiency; Respiratory Insufficiency

2015